Source 1primary paper2025MED
Toolkit/DETECTR
DETECTR
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Emerging CRISPR-based diagnostics (e.g., SHERLOCK and DETECTR)
Usefulness & Problems
Why this is useful
DETECTR is named as an emerging CRISPR-based diagnostic in the review abstract. It is discussed in the context of enhancing safety, stratification, and monitoring of CRISPR therapeutics.; CRISPR-based diagnostics; safety enhancement; patient stratification; monitoring of CRISPR therapeutics
Source:
DETECTR is named as an emerging CRISPR-based diagnostic in the review abstract. It is discussed in the context of enhancing safety, stratification, and monitoring of CRISPR therapeutics.
Source:
CRISPR-based diagnostics
Source:
safety enhancement
Source:
patient stratification
Source:
monitoring of CRISPR therapeutics
Problem solved
The abstract positions DETECTR as part of the diagnostic layer supporting safer and better-monitored CRISPR therapeutic development.; supports diagnostic monitoring and stratification around CRISPR therapeutics
Source:
The abstract positions DETECTR as part of the diagnostic layer supporting safer and better-monitored CRISPR therapeutic development.
Source:
supports diagnostic monitoring and stratification around CRISPR therapeutics
Problem links
DETECTR is explicitly listed as an emerging CRISPR-based diagnostic, making it a plausible tool for rapid pathogen detection. Such platforms may help close the gap between limited tests and more specific molecular identification.
supports diagnostic monitoring and stratification around CRISPR therapeutics
LiteratureThe abstract positions DETECTR as part of the diagnostic layer supporting safer and better-monitored CRISPR therapeutic development.
Source:
The abstract positions DETECTR as part of the diagnostic layer supporting safer and better-monitored CRISPR therapeutic development.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
No mechanism tags yet.
Target processes
diagnosticeditingImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
Operational role: sensor. Implementation mode: genetically encoded. Cofactor status: cofactor requirement unknown.
Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. No canonical validation observations are stored yet, so context-specific performance remains under-specified.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
CRISPR-based diagnostics such as SHERLOCK and DETECTR, together with AI-assisted sgRNA design and machine-learning off-target prediction, enhance the safety, stratification, and monitoring of CRISPR therapeutics.
Base editing, prime editing, CRISPRi/a, and RNA-targeting Cas systems improve precision and reduce genomic damage, which is particularly advantageous in post-mitotic neurons.
Approval Evidence
1 source1 linked approval claimfirst-pass slug detectr
Emerging CRISPR-based diagnostics (e.g., SHERLOCK and DETECTR)
Source:
diagnostic supportsupports
CRISPR-based diagnostics such as SHERLOCK and DETECTR, together with AI-assisted sgRNA design and machine-learning off-target prediction, enhance the safety, stratification, and monitoring of CRISPR therapeutics.
Source:
Comparisons
Source-backed strengths
explicitly cited as an emerging CRISPR-based diagnostic
Source:
explicitly cited as an emerging CRISPR-based diagnostic
Compared with CRISPR/Cas-hybrid assays
DETECTR and CRISPR/Cas-hybrid assays address a similar problem space because they share diagnostic, editing.
Shared frame: same top-level item type; shared target processes: diagnostic, editing
Strengths here: looks easier to implement in practice.
Compared with nanotechnology-enhanced biosensors
DETECTR and nanotechnology-enhanced biosensors address a similar problem space because they share diagnostic, editing.
Shared frame: same top-level item type; shared target processes: diagnostic, editing
Compared with spatial transcriptomics
DETECTR and spatial transcriptomics address a similar problem space because they share diagnostic, editing.
Shared frame: same top-level item type; shared target processes: diagnostic, editing
Relative tradeoffs: appears more independently replicated.
Ranked Citations
- 1.